Dr. Kirwan is professor of rheumatic diseases at the University of Bristol and consultant rheumatologist at the University Hospitals Bristol NHS Foundation Trust, both in the U.K.
References
- Kersley GD. Amethopterin (methotrexate) in connective tissue disease-psoriasis and polyarthritis. Ann Rheum Dis. 1968;27:64-66.
- Hench PS, Kendall EC, Slocumb CH, Polley HF. Effects of a hormone of the adrenal cortex (17-hydroxy-11 dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis: Preliminary report. Proc Staff Meet Mayo Clin. 1949;24:181-197.
- Hench PS, Kendall EC, Slocumb CH, et al. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med. 1950;85:545-666.
- Pincus T, Marcum SB, Callahan LF. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol. 1992;19:1885-1894.
- Kirwan JR. The origins, results and consequences of the 1995 Arthritis Research Campaign Low-dose Glucocorticoid Study. Clin Exp Rheum. 2011; 29(Suppl. 68):S52-S58.
- Kirwan JR, Bijlsma JWJ, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2007;1:CD006356.
- Singh JA, Furst DE, Bharat A, et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:625-639.
- Kirwan JR. Combination therapy including glucocorticoids: The new gold standard for early treatment in rheumatoid arthritis? Ann Intern Med. 2012;156:390-391.
